Market Overview

Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc

Share:
Jim Cramer Shares His Thoughts On Gilead Sciences, Inc. And Citigroup Inc
Related GILD
Wall Street's M&A Chatter From July 26: Biomarin, Sigma Designs, Colgate-Palmolive, Markel-State National
Gilead, Juniper, United, Wynn: Fast Money Picks For July 27
Biotech Fever Cools As These Players Dip On Longer-Term Views (Investor's Business Daily)
Related C
How The Volatility Of Earnings Season Can Affect Leveraged ETFs
A Look Back At PayPal's Impressive Week
Schnieders Capital Management Llc Buys Comcast Corp, Citigroup Inc, SPDR Select Sector Fund - ... (GuruFocus)

On CNBC's Mad Money, Jim Cramer said that Gilead Sciences, Inc. (NASDAQ: GILD) has to do an acquisition. Without it, the stock is not going to move higher, because the company has a lot of cash and not a lot of growth.

Cramer thinks Citigroup Inc (NYSE: C) was well prepared for the stress test, and he believes it is a buy at its current price.

Posted-In: Jim CramerBiotech CNBC Long Ideas Jim Cramer Media Trading Ideas General

 

Related Articles (GILD + C)

View Comments and Join the Discussion!